您的位置:首页 > 产品中心 > 110703-94-1, 唑泊司他
唑泊司他
Zopolrestat
产品别名
110703-94-1
唑泊司他
Zopolrestat
CP-73850
Alond
3,4-Dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid
Xedia
结构式
基本信息
Empirical Formula【经验(实验)分子式】 | C19H12F3N3O3S |
Molecular weight | 419.38 |
MDL number | MFCD00865476 |
PubChem Substance ID【PubChem化学物质编号】 | 329831615 |
NACRES | NA.77 |
Biochem/physiol Actions【生化/生理作用】 | Zopolrestat is an inhibitor of Aldose Reductase. AR family members AKR1B1 and AKR1B10 have additionally been shown to play roles in inflammation and cancer. |
Features and Benefits【特点和优势】 | This compound is featured on the Dopamine and Norepinephrine Metabolism page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. This compound was developed by Pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
Legal Information【法律信息】 | Pfizer is a registered trademark of Pfizer, Inc. |
产品性质
Quality Level【质量水平】 | 100 |
Assay【测定】 | ≥98% (HPLC) |
form【形式】 | powder |
manufacturer/tradename | Pfizer® |
color【颜色】 | off-white to light brown |
solubility【溶解性】 | DMSO: ≥20 mg/mL |
originator【创始人】 | Pfizer |
storage temp.【储存温度】 | 2-8℃ |
SMILES string | OC(=O)CC1=NN(Cc2nc3cc(ccc3s2)C(F)(F)F)C(=O)c4ccccc14 |
InChI | 1S/C19H12F3N3O3S/c20-19(21,22)10-5-6-15-14(7-10)23-16(29-15)9-25-18(28)12-4-2-1-3-11(12)13(24-25)8-17(26)27/h1-7H,8-9H2,(H,26,27) |
InChI key | BCSVCWVQNOXFGL-UHFFFAOYSA-N |
packaging【包装】 | 10, 50 mg in glass bottle |
安全信息
Pictograms【象形图】 | GHS06 |
Signal word【警示用语:】 | Danger |
Hazard Statements | H301 - H413 |
Precautionary Statements | P273 - P301 + P310 + P330 |
Hazard Classifications【危险分类】 | Acute Tox. 3 Oral - Aquatic Chronic 4 |
Storage Class Code【储存分类代码】 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
WGK | WGK 3 |